US biotechnology EIT Pharma, which focused on advancing therapies for infectious diseases, today appointed Dr Jose Toerne as ...

The diagnosed prevalent cases of ulcerative colitis (UC) in the seven major markets (7MM: The USA, France, Germany, Italy, ...

AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved in the European Union (EU) as a ...

Swiss pharma giant Novartis’ shares edged up 2% to 130.00 in early trading as the company reported third quarter 2026 ...

US clinical-stage biopharma Corxel Pharmaceuticals, which is focused on developing innovative oral therapies for obesity and ...

Chiesi Global Rare Diseases, the rare diseases business unit of Italy’s family-run Chiesi Group, announced three poster ...

German pharma and life sciences company Merck KGaA today announced new two-year follow-up results from the Phase III MANEUVER ...

US precision oncology company IDEAYA Biosciences and partner Servier presented updated data from three trials of the oral PKC ...

China is emerging as an innovation hub in the rapidly diversifying global obesity drug landscape, with domestic drugmakers ...

The US Food and Drug Administration (FDA) has expanded approval of Pfizer’s Talzenna (talazoparib) in combination with Xtandi (enzalutamide ...

Cambridge, USA based Spero Therapeutics, which is focused on developing advanced medicines for serious immune-mediated ...

The US Centers for Medicare and Medicaid Services (CMS) has released the final guidelines for implementation of the GLOBE ...